SNP-based Microdeletion and Aneuploidy RegisTry (SMART)

CompletedOBSERVATIONAL
Enrollment

20,960

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
22q11 Deletion SyndromeDiGeorge SyndromeTrisomy 21Trisomy 18Trisomy 13Monosomy XSex Chromosome AbnormalitiesCri-du-Chat SyndromeAngelman SyndromePrader-Willi Syndrome1p36 Deletion Syndrome
Trial Locations (21)

1

Royal College Surgeons in Ireland, Dublin

2050

Royal Prince Alfred, Camperdown

10016

New York University, New York

10029

Icahn School of Medicine Mt Sinai, New York

10032

Columbia University, New York

10461

Montefiore Medical Center, New York

11030

North Shore University Hospital, Manhasset

11040

Long Island Jewish Medical Center, New Hyde Park

11501

Madonna Perinatal, Mineola

11530

Complete Women's Healthcare, Garden City

11777

Suffolk OB, Port Jefferson

75601

Zeid Women's Health Center, Longview

78758

North Austin Maternal Fetal Medicine, Austin

84132

University of Utah, Salt Lake City

94158

University of California, San Francisco, San Francisco

08103

Cooper University Hospital, Camden

08054

Virtua, Mount Laurel

08901

St. Peter's University, New Brunswick

08028

Dexeus, Barcelona

SE-416 85

Sahlgrenska University Hospital, Gothenburg

SW17 0QT

St. George University Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

George Washington University

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

Montefiore Medical Center

OTHER

collaborator

Children's Hospital of Philadelphia

OTHER

lead

Natera, Inc.

INDUSTRY

NCT02381457 - SNP-based Microdeletion and Aneuploidy RegisTry (SMART) | Biotech Hunter | Biotech Hunter